Invention Grant
- Patent Title: Psilocybin and/or psilocin in combination with cannabinoids and/or terpenes
-
Application No.: US16478283Application Date: 2018-01-18
-
Publication No.: US10729706B2Publication Date: 2020-08-04
- Inventor: Murat Küçüksen , Ali Neset Küçüksen
- Applicant: Procare Beheer B.V.
- Applicant Address: NL Hazerswoude-Dorp
- Assignee: Procare Beheer B.V.
- Current Assignee: Procare Beheer B.V.
- Current Assignee Address: NL Hazerswoude-Dorp
- Agency: Hoffmann & Baron, LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@5e23d3a4
- International Application: PCT/NL2018/050037 WO 20180118
- International Announcement: WO2018/135943 WO 20180726
- Main IPC: A61K31/675
- IPC: A61K31/675 ; A61K31/04 ; A61K31/015 ; A61K31/355 ; A61P25/28 ; A61P25/22 ; A61P25/18 ; A61P25/24 ; A61K31/352 ; A61K31/4045
Abstract:
One or more cannabinoids and/or terpenes in combination with psilocybin and/or psilocin may be used in the prevention or treatment of psychological or brain disorders. The one or more cannabinoids may be taken from the group of cannabidiol (CBD); cannabidiolic acid (CBDA); tetrahydrocannbidivarin (THCV); tetrahydrocannbidivarinin acid (THCVA); cannabichromene (CBC); cannabichromenic acid (CBCA); cannabigerol (CBG) and cannabigerolic acid (CBGA).
Public/Granted literature
- US20190350949A1 PSILOCYBIN AND/OR PSILOCIN IN COMBINATION WITH CANNABINOIDS AND/OR TERPENES Public/Granted day:2019-11-21
Information query
